Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials

We evaluated the role of early response after 3 weeks of neoadjuvant treatment (NAT) assessed by ultrasound (US), magnetic resonance imaging (MRI) and Ki‐67 dynamics for prediction of pathologic complete response (pCR) in different early breast cancer subtypes. Patients with HR+/HER2+, HR−/HER2− and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Graeser, Monika, Schrading, Simone, Gluz, Oleg, Strobel, Kevin, Würstlein, Rachel, Kümmel, Sherko, Schumacher, Claudia, Grischke, Eva‐Maria, Forstbauer, Helmut, Braun, Michael, Christgen, Matthias, Adams, Jascha, Nitzsche, Henrik, Just, Marianne, Fischer, Hans Holger, Aktas, Bahriye, Potenberg, Jochem, von Schumann, Raquel, Kolberg‐Liedtke, Cornelia, Harbeck, Nadia, Kuhl, Christiane K., Nitz, Ulrike
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Tumor Markers and Signatures
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048810/
https://ncbi.nlm.nih.gov/pubmed/33533487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados